Related Experiment Videos
Liver disease in the immunocompromised patient
1Department of Pathology, Yale University School of Medicine, New Haven, CT 06520-8023, USA.
Pathology (Philadelphia, Pa.)
|January 1, 1994
Summary
This review covers common liver diseases in patients with immunodeficiencies from AIDS, cancer therapy, and transplants. It details liver disease, infections, and graft-versus-host disease in immunocompromised individuals.
Area of Science:
- Hepatology
- Immunology
- Oncology
Background:
- Immunodeficiency compromises liver health.
- AIDS, cancer treatments, and transplants increase liver disease risk.
- Understanding these conditions is crucial for patient care.
Purpose of the Study:
- To review common liver diseases in immunocompromised patients.
- To discuss liver conditions associated with AIDS, chemotherapy, radiation, and transplantation.
- To provide an overview of specific liver pathologies.
Main Methods:
- Literature review of common liver diseases in immunocompromised states.
- Synthesis of information on conditions like liver disease, infection, veno-occlusive disease, and graft-versus-host disease.
- Categorization of liver pathologies based on underlying immunodeficient causes.
Main Results:
- Identified key liver diseases linked to AIDS, chemotherapy, radiation, and transplantation.
- Detailed descriptions of liver disease, infection, veno-occlusive disease, and graft-versus-host disease.
- Highlighted the spectrum of hepatic complications in immunocompromised populations.
Conclusions:
- Liver diseases are prevalent in immunocompromised patients.
- Specific conditions require tailored management strategies.
- Further research is needed to optimize treatment for these complex cases.